Nonredundant Functions for Tumor Protein D52-Like Proteins Support Specific Targeting of TPD52
暂无分享,去创建一个
Nikolajs Zeps | Rosette Lidereau | Jennifer A Byrne | R. K. Bright | Karen Byth | K. Byth | I. Bièche | N. Zeps | R. Lidereau | J. Byrne | S. Fanayan | M. Shehata | Ivan Bièche | R. Boutros | Rose Boutros | Susan Fanayan | Mona Shehata | Judith Weidenhofer | Lisa Spalding | Robert K Bright | J. Weidenhofer | L. Spalding | Mona Shehata
[1] Howard Y. Chang,et al. Genetic regulators of large-scale transcriptional signatures in cancer , 2006, Nature Genetics.
[2] S. Knuutila,et al. DNA copy number amplification profiling of human neoplasms , 2006, Oncogene.
[3] J. Benítez,et al. The Accumulation of Specific Amplifications Characterizes Two Different Genomic Pathways of Evolution of Familial Breast Tumors , 2005, Clinical Cancer Research.
[4] P. Gunning,et al. Identification of homo- and heteromeric interactions between members of the breast carcinoma-associated D52 protein family using the yeast two-hybrid system , 1998, Oncogene.
[5] G. Sherlock,et al. The prognostic role of a gene signature from tumorigenic breast-cancer cells. , 2007, The New England journal of medicine.
[6] S. Paik,et al. Technology Insight: application of molecular techniques to formalin-fixed paraffin-embedded tissues from breast cancer , 2005, Nature Clinical Practice Oncology.
[7] Tian-Li Wang,et al. Notch3 gene amplification in ovarian cancer. , 2006, Cancer research.
[8] Margaret Gardiner-Garden,et al. Overexpression of the Cell Adhesion Molecules DDR1, Claudin 3, and Ep-CAM in Metaplastic Ovarian Epithelium and Ovarian Cancer , 2004, Clinical Cancer Research.
[9] Alberto Riva,et al. Defining aggressive prostate cancer using a 12-gene model. , 2006, Neoplasia.
[10] S. Pileri,et al. Tumor protein D52 (TPD52): a novel B-cell/plasma-cell molecule with unique expression pattern and Ca(2+)-dependent association with annexin VI. , 2005, Blood.
[11] Borja Saez,et al. Identification of overexpressed genes in frequently gained/amplified chromosome regions in multiple myeloma. , 2006, Haematologica.
[12] Ning Weng,et al. Identification of Annexin VI as a Ca2+-sensitive CRHSP-28-binding Protein in Pancreatic Acinar Cells* , 2002, The Journal of Biological Chemistry.
[13] I. Bièche,et al. Identification of a three-gene expression signature of poor-prognosis breast carcinoma , 2004, Molecular Cancer.
[14] S. Dhanasekaran,et al. Integrative analysis of genomic aberrations associated with prostate cancer progression. , 2007, Cancer research.
[15] David I. Smith,et al. Induction of Tumorigenesis and Metastasis by the Murine Orthologue of Tumor Protein D52 , 2007, Molecular Cancer Research.
[16] P. Nelson,et al. PrLZ, a Novel Prostate-Specific and Androgen-Responsive Gene of the TPD52 Family, Amplified in Chromosome 8q21.1 and Overexpressed in Human Prostate Cancer , 2004, Cancer Research.
[17] P. Gunning,et al. The 3′-end of the human β-actin gene enhances activity of the β-actin expression vector system: construction of improved vectors , 1997 .
[18] C. Clarke,et al. The hD52 (TPD52) gene is a candidate target gene for events resulting in increased 8q21 copy number in human breast carcinoma , 2000, Genes, chromosomes & cancer.
[19] N. Kohl,et al. Lung cancer cell lines harboring MET gene amplification are dependent on Met for growth and survival. , 2007, Cancer research.
[20] Zuo-min Zhou,et al. A testis-specific and testis developmentally regulated tumor protein D52 (TPD52)-like protein TPD52L3/hD55 interacts with TPD52 family proteins. , 2006, Biochemical and biophysical research communications.
[21] C. Collins,et al. High‐resolution array comparative genomic hybridization of chromosome arm 8q: Evaluation of genetic progression markers for prostate cancer , 2005, Genes, chromosomes & cancer.
[22] S. H. Wilson,et al. Alternative splicing as a mechanism for regulating 14-3-3 binding: interactions between hD53 (TPD52L1) and 14-3-3 proteins. , 2003, Journal of molecular biology.
[23] D. Allred,et al. Development of Standard Estrogen and Progesterone Receptor Immunohistochemical Assays for Selection of Patients for Antihormonal Therapy , 2007, Applied immunohistochemistry & molecular morphology : AIMM.
[24] S. L. Wong,et al. Towards a proteome-scale map of the human protein–protein interaction network , 2005, Nature.
[25] K. Byth,et al. Tumor protein D52 (TPD52) is overexpressed and a gene amplification target in ovarian cancer , 2005, International journal of cancer.
[26] L. Chung,et al. PC-1/PrLZ contributes to malignant progression in prostate cancer. , 2007, Cancer research.
[27] M. K. Byeon,et al. Characterization of human N8 protein , 1997, Oncogene.
[28] Christian A. Rees,et al. Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[29] Jorma Isola,et al. Patterns of chromosomal imbalances defines subgroups of breast cancer with distinct clinical features and prognosis. A study of 305 tumors by comparative genomic hybridization. , 2003, Cancer research.
[30] Wonshik Han,et al. Genomic alterations identified by array comparative genomic hybridization as prognostic markers in tamoxifen-treated estrogen receptor-positive breast cancer , 2006, BMC Cancer.
[31] W. Sellers,et al. Overexpression, Amplification, and Androgen Regulation of TPD52 in Prostate Cancer , 2004, Cancer Research.
[32] Steven Ma,et al. Principal Component Analysis in Linear Regression Survival Model with Microarray Data , 2021, Journal of Data Science.
[33] C. Sotiriou,et al. Taking gene-expression profiling to the clinic: when will molecular signatures become relevant to patient care? , 2007, Nature Reviews Cancer.
[34] Peter W. Andrews,et al. Novel Genomic Aberrations in Testicular Germ Cell Tumors by Array-CGH, and Associated Gene Expression Changes , 2006, Cellular oncology : the official journal of the International Society for Cellular Oncology.
[35] Johan Staaf,et al. High‐resolution genomic profiles of breast cancer cell lines assessed by tiling BAC array comparative genomic hybridization , 2007, Genes, chromosomes & cancer.
[36] J. Pollack,et al. RNA interference‐based functional dissection of the 17q12 amplicon in breast cancer reveals contribution of coamplified genes , 2006, Genes, chromosomes & cancer.
[37] S. Hirohashi,et al. Genome‐wide array‐based comparative genomic hybridization analysis of pancreatic adenocarcinoma: Identification of genetic indicators that predict patient outcome , 2007, Cancer science.
[38] Kenny Q. Ye,et al. Novel patterns of genome rearrangement and their association with survival in breast cancer. , 2006, Genome research.
[39] Jennifer A Byrne,et al. The tumor protein D52 family: many pieces, many puzzles. , 2004, Biochemical and biophysical research communications.
[40] A. Dutra,et al. Chromosome 8 BAC array comparative genomic hybridization and expression analysis identify amplification and overexpression of TRMT12 in breast cancer , 2007, Genes, chromosomes & cancer.
[41] Jennifer A Byrne,et al. D53 (TPD52L1) is a cell cycle-regulated protein maximally expressed at the G2-M transition in breast cancer cells. , 2005, Experimental cell research.
[42] C. Nourse,et al. Identification of MAL2, a novel member of the mal proteolipid family, though interactions with TPD52-like proteins in the yeast two-hybrid system. , 2001, Genomics.